Merck Group & Thermo Fisher Scientific

Merck Group: Merck Group is listed among the top companies in the epigenetics market, suggesting its involvement and potential for growth within this expanding sector.

Thermo Fisher Scientific: Thermo Fisher Scientific is identified as a top company in the epigenetics market, indicating its strong position and potential to benefit from market growth.

Merck Group: Merck Group is acquiring Bio-Techne — Bio-Techne Diagnostics Corporation to expand its life sciences business, reduce reliance on marketed drugs, and strengthen its position in high-growth areas like multi-omics and cell and gene therapy. This acquisition is its largest in over a decade and is expected to be immediately accretive to sales growth and EBITDA pre margin.

Thermo Fisher Scientific: Thermo Fisher Scientific is mentioned as another big U.S. life-science company that has made multibillion-dollar acquisitions, indicating a trend in the industry that Merck Group is following.